Johnson & Johnson’s Oncology Pipeline Gains Momentum with Dual Drug Approvals
Facing the impending loss of patent protection for its key immunology drug Stelara, Johnson & Johnson is strategically bolstering its...
Facing the impending loss of patent protection for its key immunology drug Stelara, Johnson & Johnson is strategically bolstering its...
In a strategic move to bolster domestic production of critical materials, MP Materials has secured a 120-hectare site in Northlake,...
The exponential energy demands of artificial intelligence are creating unprecedented challenges for major technology firms, as conventional power grids increasingly...
In a significant coup for the South Korean semiconductor industry, SK Hynix has secured an exclusive position as a memory...
A fatal accident at Aurubis AG's primary Hamburg facility has cast a shadow over the copper producer's operations. The incident,...
A significant shift in its market listing underscores the current difficulties for Carl Zeiss Meditec. The medical technology firm is...
Nokia finds itself under the dual spotlight of regulatory filings and strategic transformation. In a significant move, asset management giant...
The price of crude oil has surged past the psychologically significant threshold of $100 per barrel. This milestone, reached for...
For investors navigating turbulent financial markets, gold's historical role as a store of value often comes to the fore. The...
Strategy Inc. has executed another significant expansion of its cryptocurrency holdings. A recent filing with the U.S. Securities and Exchange...
StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.
© 2023 StocksToday.com